Minimally Invasive Surgery Market Growth Analysis - Market Size, Share, Forecast Trends and Outlook Report (2025-2034)

The global minimally invasive surgery market was valued at USD 79.30 Billion in 2024, driven by the growing incidences of cardiovascular and other diseases coupled with the rising demand for surgical procedures allowing faster recovery across the globe. The market is anticipated to grow at a CAGR of 12.10% during the forecast period of 2025-2034 to achieve a value of USD 248.50 Billion by 2034.

Minimally Invasive Surgery Market Overview

Minimally invasive surgery (MIS) involves surgical procedures that use small incisions, specialised instruments, and advanced technology such as cameras and robotic systems, reducing the need for large cuts. This approach aims to minimise patient discomfort, reduce recovery time, and lower the risk of infection. Commonly used for procedures like laparoscopy, arthroscopy, and endoscopy, MIS is employed in various medical fields including orthopaedics, urology, and gynaecology. The primary benefits include quicker healing, less scarring, and shorter hospital stays, improving overall patient outcomes and satisfaction.

Minimally Invasive Surgery Market Growth Drivers

Innovations in Embolization Systems to Drive Market Growth

In March 2024, CERENOVUS Inc. launched the TRUFILL n-BCA Liquid Embolic System Procedural Set, a new addition to its hemorrhagic stroke portfolio. This procedural set includes two configurations and the necessary accessories to prepare and deliver the n-BCA liquid embolic system, all sterilised within one set, streamlining the preparation process for physicians. This embolization system is used for pre-surgical devascularisation, reducing bleeding risks in surgery, and making inoperable arteriovenous malformations (AVMs) operable. The TRUFILL system offers lower fluoroscopy times and potential procedural cost reductions compared to competitors, with customisable solutions for individual patients. The system also boasts a lower incidence of microcatheter retention. These improvements in both safety and cost-efficiency will further fuel the adoption of embolization techniques in minimally invasive surgeries, significantly contributing to market growth during the forecast period.

Miniaturized Robotic Surgery Systems to Boost Minimally Invasive Surgery Market Demand

In February 2024, Virtual Incision Corporation received FDA marketing authorisation for its MIRA Surgical System, the first miniaturised robotic-assisted surgery (miniRAS) device designed for adults undergoing colectomy procedures. MIRA was approved through the FDA’s De Novo Classification process, intended for devices that have no legally marketed predicate. The FDA approval was based on results from the company’s U.S. Investigational Device Exemption (IDE) clinical study, which showed the system’s efficacy. MIRA is designed to assist with minimally invasive surgeries by enabling smaller incisions, reduced recovery times, and improved precision. This development in robotic surgery technology will enhance the overall performance and efficiency of minimally invasive surgeries, marking a significant advancement that is expected to drive continued growth in the market, particularly in colorectal surgeries, during the forecast period.

Minimally Invasive Surgery Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Robotic-Assisted Surgery Adoption to Promote Market Growth

The adoption of robotic-assisted surgery continues to surge in the minimally invasive surgery market. Robotic systems, offering high precision, flexibility, and control, enhance surgical outcomes while reducing recovery times. These systems are increasingly used for complex procedures, offering advantages like smaller incisions and reduced risk of complications. With advancements in technology, robotic surgery is becoming more accessible to healthcare facilities, which is expected to accelerate its adoption. As more surgeons incorporate robotic systems into their practices, the global minimally invasive surgery market will see continued growth in the coming years.

Growing Outpatient Surgery Centres to Enhance Minimally Invasive Surgery Market Growth

Outpatient surgery centres are increasingly becoming preferred for minimally invasive procedures due to reduced costs, shorter recovery times, and the ability to perform a wide range of surgeries. This trend is driving global market expansion, as patients seek more efficient and affordable alternatives to traditional hospital settings. Outpatient centres, equipped with state-of-the-art technology, can perform minimally invasive surgeries, resulting in faster procedures and reduced healthcare costs. This shift towards outpatient care, coupled with advancements in surgical techniques, will continue to contribute to the growth of the minimally invasive surgery market.

Imaging Technology Advancements Improving Precision to Promote Minimally Invasive Surgeries Market Value

Innovations in imaging technologies, such as 3D imaging, fluoroscopy, and real-time MRI, are revolutionising minimally invasive surgeries. These technologies allow surgeons to visualise the surgery area more clearly, improving precision and reducing complications. Enhanced imaging provides surgeons with detailed views of tissues, blood vessels, and other structures, allowing for more accurate incisions and procedures. As imaging technologies evolve, they play an integral role in ensuring patient safety and improving outcomes. This trend will significantly drive the adoption of minimally invasive surgeries across various surgical specialities during the forecast period.

Increasing Adoption of New Technologies to Enhance Minimally Invasive Surgery Market Size

In January 2024, Arthrex, a prominent leader in minimally invasive surgical technology, launched TheNanoExperience.com, a new platform focused on educating patients about Nano arthroscopy. This advanced orthopedic procedure offers a minimally invasive approach, enabling quicker recovery and less postoperative pain compared to traditional arthroscopic techniques. By providing detailed resources and promoting the benefits of nano arthroscopy, Arthrex is enhancing patient awareness and driving the adoption of this technology. As patients increasingly seek faster recovery options with less discomfort, the demand for such advanced procedures is poised to grow, contributing to the expansion of the market in the forecast period.

Minimally Invasive Surgery Market Segmentation

Minimally Invasive Surgery Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Surgical Devices
• Handheld Instruments Laser Fiber Devices Probes Suturing Instruments Dilators Tubular Retractors
• Guiding Devices Guiding Catheters Guidewires
• Inflation Systems Balloon Catheters Balloon Inflation Systems
• Laparoscopy Devices Laparoscopes Trocars & Cannulas Graspers & Dissectors
• Imaging & Visualization Systems
• Ultrasound Systems
• CT Scanners
• MRI Systems
• X-Ray Systems
• Visualization Systems
• Electrosurgical Devices
• Electrocautery Devices
• Electrosurgical Generators & Accessories
• Endoscopy Devices
• Rigid Endoscopes
• Flexible Endoscopes
• Diagnostic Endoscopes
• Medical Robotics
• Robotic Systems
• Robotic Instruments
• Robotic Software & Services
• Others

Market Breakup by Application

• Cardiovascular Surgery
• Orthopedic Surgery
• Gastrointestinal & Abdominal Surgery
• ENT & Respiratory Surgery
• Gynecological Surgery
• Urological
• Dental Surgery
• Others

Market Breakup by End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Research Institutions
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Minimally Invasive Surgery Market Share

Endoscopy Devices to Lead the Product Segment

Endoscopy devices are poised to hold a substantial market share based on product. As per the analysis by Expert Market Research, the global endoscopy devices market is expected to grow at a CAGR of 6.2% during the forecast period of 2025-2034. The growing preference for minimally invasive procedures, driven by factors such as reduced recovery times and lower risk of complications, has significantly boosted demand for endoscopy devices. The continuous advancements in technology, such as high-definition imaging and 3D visualization systems, are enhancing their efficacy and precision. As healthcare providers increasingly adopt minimally invasive techniques in various surgeries, the endoscopy devices segment is expected to dominate, with continued growth in both diagnostic and therapeutic applications driving the market in the forecast period.

Cardiovascular Surgery to Hold a Significant Minimally Invasive Surgery Market Value for the Application Segment

Cardiovascular surgery is projected to hold the largest market share within the application segment. The increasing prevalence of cardiovascular diseases (CVDs), coupled with the rising demand for less invasive procedures, positions cardiovascular surgeries as a significant growth driver. As per the analysis by Expert Market Research, the global cardiovascular stents market is expected to grow at a CAGR of 4.80% during the forecast period 2025-2034. Minimally invasive techniques in cardiac surgery, such as catheter-based interventions and endovascular procedures, offer reduced recovery time, lower risk of infection, and improved patient outcomes. As technological advancements in imaging and surgical tools continue, the cardiovascular surgery segment is set to experience substantial growth, contributing significantly to the overall market expansion.

Hospitals and Clinics to Lead the Minimally Invasive Surgery Market by End User Segment

Hospitals and clinics are set to hold the largest market share by end user. These healthcare facilities continue to adopt minimally invasive procedures due to their benefits of quicker recovery times and reduced complications. The increasing demand for minimally invasive surgeries in hospitals and clinics is driven by advancements in surgical technology, better patient outcomes, and the growing burden of chronic diseases. As more procedures move from traditional to minimally invasive methods, this segment will remain dominant, further propelling the market’s growth in the forecast period, particularly as surgical capacities expand globally.

Minimally Invasive Surgery Market Analysis by Region

North America is poised to hold the largest share of the market, driven by advanced healthcare infrastructure, high adoption of robotic-assisted procedures, and increasing demand for outpatient surgeries. The region benefits from strong reimbursement policies and continuous innovations in laparoscopic and robotic technologies, making MIS more accessible. Meanwhile, Europe is experiencing growth due to rising geriatric populations and technological advancements. The Asia Pacific market is expanding rapidly with increasing medical tourism and healthcare investments. Latin America and the Middle East & Africa show steady growth, primarily driven by improving healthcare facilities and rising awareness of minimally invasive techniques. North America’s leadership is expected to persist due to sustained technological advancements and strong market investments.

Leading Players in the Minimally Invasive Surgery Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Stryker Corporation

Founded in 1941 and headquartered in Michigan, USA, Stryker Corporation is a global leader in medical technology, specialising in minimally invasive surgery (MIS). The company offers advanced surgical instruments, endoscopic systems, and robotic-assisted technologies, including the MAKO robotic-arm-assisted platform for orthopaedic procedures. For instance, In August 2024, Stryker announced a definitive agreement to acquire Vertos Medical Inc., a provider of minimally invasive solutions for chronic lower back pain caused by lumbar spinal stenosis. This acquisition strengthens Stryker’s MIS portfolio, enhancing patient outcomes by offering innovative, less invasive treatments that improve mobility, reduce recovery times, and address the growing demand for advanced spinal care solutions.

Conmed Corporation

Conmed Corporation, established in 1970 and headquartered in New York, USA, specialises in medical devices for minimally invasive surgery. The company provides a comprehensive range of products, including arthroscopy, electrosurgery, endoscopic instruments, and surgical visualisation technologies. Conmed’s advanced solutions cater to orthopaedics, gastroenterology, and general surgery, supporting surgeons with precise and efficient tools. With a strong emphasis on innovation and surgeon-centric designs, the company continuously develops new technologies to enhance procedural outcomes and patient recovery, strengthening its position in the global minimally invasive surgery market.

Intuitive Surgical Operations, Inc

Intuitive Surgical Operations, Inc., founded in 1995 and headquartered in California, USA, is a leader in robotic-assisted minimally invasive surgery. Renowned for its da Vinci Surgical System, the company enhances precision in urology, gynaecology, and general surgery, improving patient outcomes through reduced invasiveness and faster recovery. In June 2024, Intuitive (NASDAQ: ISRG) announced FDA clearance for a labelling revision on da Vinci X and Xi for radical prostatectomy. This approval was based on real-world evidence (2007-2014) showing comparable five- to 10-year survival rates between robotic-assisted and non-robotic radical prostatectomy, reinforcing Intuitive’s role in advancing surgical innovation.

NuVasive, Inc

Founded in 1997 and headquartered in California, USA, NuVasive, Inc. is a leading medical device company specialising in minimally invasive spine surgery. The company is renowned for its advanced spinal implants, neuromonitoring systems, and robotic-assisted surgical solutions, particularly in lateral access spine procedures. In November 2022, NuVasive expanded its portfolio with the launch of the NuVasive Tube System (NTS) and Excavation Micro, enhancing minimally invasive solutions for TLIF and decompression. Its flagship XLIF® procedure has revolutionised spinal surgery by reducing tissue disruption and recovery times. Committed to innovation, NuVasive continues advancing spinal alignment technologies, improving patient outcomes, and transforming spine surgery globally.

Other key players in the market include Fortimedix Surgical B.V., Microline Surgical Inc., Arthrex, Inc., Eximis Surgical, Inc., and Cirtec Medical Corporation.

Key Questions Answered in the Minimally Invasive Surgery Market

• What was the global minimally invasive surgery market value in 2024?
• What is the minimally invasive surgery market forecast outlook for 2025-2034?
• What is market segmentation based on product?
• What is market segmentation based on application?
• What is market segmentation based on end users?
• What are the major factors aiding the minimally invasive surgery market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major minimally invasive surgery market trends?
• Which product will lead the market segment?
• Which application will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the minimally invasive surgery market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.